nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancer

Hamiton, E.Cortes, J.Dieras, V.Ozyilkan, O.Chen, S-C.Petrakova, K.Manikhas, A.Jerusalem, G.Hegg, R.Lu, Y.Bear, M.M.Johnston, E.L.Martin, M.2020-12-242020-12-2420190008-5472http://hdl.handle.net/11727/5135enginfo:eu-repo/semantics/closedAccessnextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancerconferenceObject794000478677002388